Ghent (Belgium), 13 February 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products, welcomes you to invest in its shares.
Media
Check out all our news
13 February 2024
bonyf R&D creates major breakthrough with 100% natural-origin ingredients new denture fixative cream
11 January 2024
22 December 2023
20 July 2023
30 June 2023
12 May 2023
24 February 2023
13 February 2023
21 December 2022
14 September 2022
19 July 2022
30 June 2022
15 June 2022
8 June 2022
1 June 2022
1 June 2022
11 May 2022
10 May 2022
06 April 2022
01 April 2022
20 March 2022
17 March 2022
15 March 2022
01 March 2022
16 December 2021
29 October 2021
01 July 2021
30 March 2021
26 January 2021
Press Releases
In the Press
Latest News
Press Releases
New Key Partnerships
Ghent (Belgium), 11 January 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is thrilled to share that bonyf has secured key partnerships with an Austria-German multinational and a leading pharma company in Ukraine.
Trading Resume under Euronext
Ghent (Belgium), 22 December 2023, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, had asked for its shares to be suspended from trading following interest from a strategic investor in acquiring a 30% stake.
bonyf’s 2022 financial statements made available
Ghent (Belgium), 20 July 2023, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, presents its 2022 consolidated financial statements, approved by its Board of Directors and audited by its Statutory Auditors
Delay in release of financial statements 2022
Ghent (Belgium), 30 June 2023; bonyf NV (Mnemonic: MLBON), a leading manufacturer of oral and denture care products announces its delay in the preparation and audit of the financial statements for the 2022 financial year.
Trading Suspension
Ghent (Belgium), 24 February 2023, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces the suspension of the listing of its shares at the request of the company.
25% increase in turnover in H1 2022
Ghent (Belgium), 14 September, 2022, 6 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces a strong growth in turnover for the first half of 2022 ...
Annual results 2021
Ghent (Belgium), 30 June, 2022, 7 p.m.; bonyf NV (ticker symbol: MLBON), the next-generation oral comfort expert, presents its 2021 financial statements, approved by ...
bonyf accelerates its export dynamics signing two new commercial contracts in Southeast Asia
Ghent (Belgium), 15 June 2022, 08.00am; bonyf NV (Mnemonic: MLBON), the next generation oral comfort expert, announces further geographic expansion ...
bonyf appoints Ben Mettepenningen as International Business Manager
Ghent (Belgium), 1 June 2022, 6.00pm; bonyf NV (Mnemonic: MLBON), the next generation oral comfort expert, announces the appointment of Mr. Ben Mettepenningen as ...
Bleeding while brushing teeth is a sign of gum disease, a condition linked to the development of Alzheimer’s disease
Ghent (Belgium), 10 May 2022, 08.00am; bonyf NV (Mnemonic: MLBON), the next generation oral comfort expert, supports International Gum Health Day 2022 and ...
Are vaseline-based denture creams a cause for health concern? bonyf offers an alternative solution to this latest controversy
Ghent (Belgium), 6 April 2022, 06.00pm; bonyf NV (ticker: MLBON), experts in next-generation oral and dental care and the producer of OlivaFix® Gold, the first and ...
bonyf raises awareness on World Oral Health Day
Ghent (Belgium), 20 March 2022, 08.00am; bonyf NV (ticker: MLBON), experts in next generation oral and dental care, joins World Oral Health Day on 20 March 2022 in emphasising the importance of oral care, your mouth being a vital organ for the prevention of many diseases.
First day of listing and start of trading on Euronext Access
Ghent (Belgium), 17 March 2022, 08:45 am; bonyf NV (Ticker symbol: MLBON), the experts in next-generation oral and dental care, announces its listing today on the Euronext Access Paris Stock
bonyf announces listing on Paris Euronext
Ghent (Belgium), 15 March 2022, 10:15am; bonyf NV (Ticker symbol: MLBON), the experts in next-generation oral and dental care, announces it will go public on Euronext Access® by direct listing on 17 March 2022.
In the Press
New personnel: Ben Mettepenningen named bonyf’s International Manager
Ben Mettepenningen has been appointed International Business Manager. In this role, Mettepenningen will be responsible for the global sales and marketing activities of the Vaduz-based oral hygiene specialist.
Liechtenstein-based bonyf strengthens its management team to enhance further expansion. With sales specialist Ben Mettepenningen on board, the company wants to open up new markets
With it’s headquarters and R&D in Vaduz and production in Buchs, bonyf develops and produces dental and oral care products. Founder and CEO, Jean-Pierre Bogaert, wants to conquer new markets.
DENTURE WEARERS: are adhesives potentially dangerous? Denture adhesive creams contain a variety of chemical ingredients that ensure their effectiveness
As these products are in the mouth for around 12 hours a day, and are in contact with the mucous membrane and are inevitably ingested, we could ask ourselves if they are completely safe.
Boursier.com: Interview With Bart De Wever, Bonyf Scientific Director. Bonyf discreetly listed on the Paris Stock Exchange, Euronext Access, the Free Aftermarket, without raising money. What is the business of the company?
Bd W .: Bonyf’s mission is to improve the lives and comfort of people suffering from oral diseases through innovative oral products. The long phase of R&D has resulted
Latest News
bonyf exhibits at the largest private label trade show
VADUZ, Liechtenstein, 12 May 2023 – bonyf, a leading manufacturer of oral and denture care products is excited to announce its participation in the Private Label Manufacturers Association's (PLMA) annual trade show in Amsterdam.
bonyf is granted TFDA approval in Taiwan
VADUZ, Liechtenstein, 13 February 2023 – To comply with new stringent regulations enforced in Taiwan for the sale of medical device products, bonyf has received the TFDA (Taiwan Food and Drug Administration) approval for 2 core products.
Inaugural shareholder newsletter released
GHENT, Belgium, 21 December 2022 – bonyf NV releases to its new shareholders the inaugural shareholder newsletter. The shareholder newsletter has been released by bonyf’s CEO and Founder, Mr Jean-Pierre Bogaert.
bonyf initiates a second clinical study to document the safety and efficacy of AphtoFix®, the company’s patented and unique muco-adhesive cream that treats mouth ulcers
VADUZ, Liechtenstein, 19 July 2022 – To comply with the new European Medical Device Regulation, bonyf has officially initiated a second clinical safety and efficacy evaluation study of its mouth ulcer cream ...
bonyf exhibits at the British Dental Conference & Dentistry Show in Birmingham
VADUZ, Liechtenstein, 11 May 2022 – bonyf will be exhibiting, together with it’s UK distributor, WHW Plastics Ltd, at the British Dental Conference & Dentistry Show in Birmingham ...
New preliminary studies are further proving PerioTabs® efficacy
VADUZ, Liechtenstein, 1 March 2022 – Researchers at the University of Zurich, Switzerland, have evaluated the prophylactic and therapeutic efficacy...
Further new clinical evidence that bonyf’s PerioTabs® reduces bleeding gums and plaque accumulation
VADUZ, Liechtenstein, 16 December, 2021 – PerioTabs®, a home-care gum and teeth brushing solution based on bonyf’s non-antibiotic biofilm removal...
bonyf’s latest innovation, PerioTabs®, performs better than chlorhexidine in treating dental implant related infections
VADUZ, Liechtenstein, 29 October 2021 – A recently published clinical trial involving 40 patients suffering from dental implant related infections...
Large TV campaign launches in Italy for bonyf’s latest innovative product, PerioTabs®
VADUZ, Liechtenstein, 1 July 2021 – PerioTabs®, a ground-breaking gum, teeth and dental implant brushing solution, is now commercially available in pharmacies throughout Italy. To increase consumer awareness...
bonyf’s innovative OlivaFix® Gold denture adhesive cream is clinically proven to have the best holding time and antimycotic effect against Candida albicans
VADUZ, Liechtenstein, 30 March 2021 – A recent research study published in the International Journal of Environmental Research and Public...
Clinical evidence affirms PerioTabs® efficacy in reducing gingival inflammation
VADUZ, Liechtenstein, 26 January 2021 – PerioTabs®, bonyf’s innovative gum and teeth brushing solution, based on the company’s proprietary anti-biofilm formulation NitrAdine®, shows high efficacy in...
bonyf’s NitrAdine® disinfecting denture tablets proven to have the highest efficacy in reducing multispecies biofilm present on dentures
VADUZ, Liechtenstein, 8 January 2021 – A recent study by the Dental School of the University of Sao Paulo in...
OlivaFix® Gold offers the best Quality of Life improvement in denture wearers when compared to well-known brands Fixodent and Corega
VADUZ, Liechtenstein, 26 November 2020 – OlivaFix® Gold, bonyf’s revolutionary organic olive oil-based denture adhesive cream, was recently evaluated for retention and
PerioTabs® kills coronavirus that causes COVID-19
VADUZ, Liechtenstein, 16 Oct 2020 – PerioTabs®, bonyf’s innovative gum and teeth brushing solution, has proven virucidal efficacy against enveloped...
bonyf initiates clinical studies for the evaluation of the efficacy of PerioTabs® for the treatment/prevention of gingivitis in young adults wearing fixed orthodontic braces
VADUZ, Liechtenstein, 27 Oct 2019, bonyf’s CSO, Dr Bart De Wever initiated two new clinical studies to evaluate the efficacy of PerioTabs® in patients wearing fixed orthodontic braces suffering from severe gingivitis.
Evidence that OlivaFix® Gold Denture Adhesive Cream reduces growth of Candida albicans presented at the 2019 World Congress in Barcelona, Spain
BARCELONA, Spain, 10 Oct 2019 – The Complutense University of Madrid in Spain recently completed a clinical trial evaluating OlivaFix® Gold Denture Adhesive Cream (OlivaFix® Gold) and a leading denture fixative cream brand with 40 denture wearers from both Spain and Portugal.
Superior results for OlivaFix® Gold Denture Adhesive Cream in large multi-centre clinical trial
VADUZ, Liechtenstein, 21 August 2019 - OlivaFix® Gold, an organic olive oil-based denture adhesive cream, free of mineral oil, Vaseline and zinc was recently evaluated in a clinical trial...
bonyf’s latest innovative product PerioTabs® – described as a “miracle product
BELGIUM, 20 June 2019 - The leading Belgian newspaper “Het Nieuwsblad” recently published an article on PerioTabs®, bonyf’s innovative product that helps reduce gum disease...
CSO for bonyf presents PerioTabs® at the 2019 “DENTis” International Congress of Dental Medicine for Students and Young Dentists conference in Romania
CLUJ-NAPOCA, Romania, 21 March 2019 - Dr Bart De Wever, CSO of bonyf presented a lecture on PerioTabs®...